Dr. Stephen Chanock is a leading expert in the discovery and characterization of cancer susceptibility regions in the human genome. He has received numerous awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes. Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. Since 1995, Dr. Chanock has served as the Medical Director for Camp Fantastic Exit Disclaimer, a week-long recreational camp for pediatric cancer patients, which is a joint venture of the NCI and Special Love, Inc.

Identification and characterization of cancer susceptibility alleles; Characterization of the scope of genetic mosaicism and its contribution to cancer risk; Investigation of the genetic architecture of cancer susceptibility; Determination of how germline variation informs our understanding of somatic alterations in cancer